Curcumin nanoformulations for modulating neuroinflammation and oxidative stress in Alzheimer's disease: blood-brain barrier transport, formulation strategies and therapeutic applications.

M Yasmin Begum; Manickam Rajkumar; Prabha Govindaraj; Nadarajan Prathap; Parappurath Narayanan Sudha; Mona Al Hamod; Hamoud Alotaibi; Deenathayalan Uvarajan

doi:10.1007/s10787-026-02381-5

SCHEDA SCIENTIFICA2026Altra ricerca

Curcumin nanoformulations for modulating neuroinflammation and oxidative stress in Alzheimer's disease: blood-brain barrier transport, formulation strategies and therapeutic applications.

M Yasmin Begum, Manickam Rajkumar, Prabha Govindaraj, Nadarajan Prathap, Parappurath Narayanan Sudha, Mona Al Hamod, Hamoud Alotaibi, Deenathayalan Uvarajan

Inflammopharmacology · 2026

Psicologia clinica Neuroscienze Psicologia cognitiva

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

CurcuminHumansAlzheimer DiseaseOxidative StressBlood-Brain BarrierAnimalsNanoparticlesNeuroinflammatory DiseasesNeuroprotective AgentsDrug Delivery SystemsAmyloid beta-PeptidesAlzheimer’s diseaseAmyloid-β aggregationNanotechnologyNeurotherapeuticsTargeted drug delivery

Come citare questo studio

M Yasmin Begum, Manickam Rajkumar, Prabha Govindaraj, Nadarajan Prathap, Parappurath Narayanan Sudha, Mona Al Hamod, Hamoud Alotaibi, Deenathayalan Uvarajan. (2026). Curcumin nanoformulations for modulating neuroinflammation and oxidative stress in Alzheimer's disease: blood-brain barrier transport, formulation strategies and therapeutic applications.. Inflammopharmacology. DOI: 10.1007/s10787-026-02381-5

Consulta la pubblicazione originale ↗